Innoviva, Inc. (INVA)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600

$19.10

-0.14 (-0.73%)

Close of Nov 06, 2026 · end-of-day data

Source: Innoviva, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$133.57M	$217.22M	$261.00M	$261.02M	$336.79M	$391.87M	$331.34M	$310.46M	$358.71M	$411.33M
Gross profit	—	—	—	—	—	—	—	$246.04M	$296.21M	$307.67M
Research & development	$1.39M	$1.35M	$0	$0	$1.79M	$576.00K	$41.43M	$33.92M	$13.65M	$30.60M
Selling, general & admin	—	—	—	—	$13.88M	$16.19M	$63.54M	$98.23M	$115.69M	$113.32M
Operating income	$108.99M	$183.60M	$238.25M	$246.36M	$321.12M	$375.10M	—	$113.89M	$166.87M	$163.75M
Interest expense	$52.42M	$43.60M	$23.95M	$18.66M	$18.33M	$19.07M	$15.79M	$19.16M	$22.21M	$16.70M
Pre-tax income	$59.63M	$134.28M	$210.25M	$232.90M	$354.25M	$445.28M	$286.95M	$194.10M	$37.39M	$326.86M
Income tax	$95.00K	$4.00K	-$196.07M	$41.90M	$60.43M	$76.44M	$66.69M	$14.38M	$14.00M	$55.70M
Net income	$59.54M	$134.14M	$395.06M	$157.29M	$224.40M	$265.85M	$213.92M	$179.72M	$23.39M	$271.17M
EBITDA	$122.94M	$197.59M	$252.12M	$260.23M	$334.96M	$388.94M	—	—	—	—
EPS (basic)	$0.54	$1.25	$3.92	$1.55	$2.21	$3.24	$3.07	$2.75	$0.37	$4.02
EPS (diluted)	$0.53	$1.17	$3.53	$1.43	$2.02	$2.87	$2.37	$2.20	$0.36	$3.30
Diluted shares	123.23M	119.87M	113.41M	113.41M	113.55M	94.31M	95.25M	86.88M	74.19M	84.76M
Gross margin	—	—	—	—	—	—	—	79.2%	82.6%	74.8%
Operating margin	81.6%	84.5%	91.3%	94.4%	95.3%	95.7%	—	36.7%	46.5%	39.8%
Net margin	44.6%	61.8%	151.4%	60.3%	66.6%	67.8%	64.6%	57.9%	6.5%	65.9%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$118.02M	$73.34M	$62.42M	$278.10M	$246.49M	$201.53M	$291.05M	$193.51M	$304.96M	$550.94M
Short-term investments	$32.42M	$55.74M	$52.49M	$72.75M	$0	$0	—	—	—	—
Inventory	—	—	—	—	—	$0	$55.90M	$40.74M	$33.73M	$39.17M
Total current assets	$198.05M	$200.37M	$199.04M	$431.23M	$342.06M	$313.67M	$443.51M	$344.22M	$554.31M	$727.51M
Goodwill	—	—	—	—	—	$0	$26.71M	$17.91M	$17.91M	$17.91M
Total assets	$379.00M	$367.34M	$548.19M	$724.83M	$999.57M	$926.39M	$1.23B	$1.24B	$1.30B	$1.64B
Total current liabilities	$20.05M	$34.74M	$5.70M	$5.37M	$6.11M	$5.81M	$134.97M	$38.13M	$236.08M	$49.70M
Short-term debt	$7.75M	—	—	—	—	$0	$96.19M	$0	$192.03M	$0
Long-term debt	$708.34M	$574.36M	$382.86M	$377.12M	$385.52M	$394.65M	$444.18M	$446.23M	$256.32M	$257.73M
Total debt	$716.09M	$574.36M	$382.86M	$377.12M	$385.52M	$394.65M	$540.37M	$446.23M	$448.34M	$257.73M
Total liabilities	$731.99M	$610.20M	$394.61M	$411.33M	$459.66M	$511.65M	$665.71M	$568.55M	$609.90M	$462.32M
Shareholders' equity	-$352.99M	-$242.86M	$153.58M	$313.50M	$539.91M	$414.74M	$565.79M	$674.96M	$691.16M	$1.17B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$60.98M	$141.75M	$223.53M	$257.46M	$313.11M	$363.81M	$201.73M	$141.06M	$188.69M	$196.93M
Capital expenditures	$278.00K	$0	$0	$12.00K	$13.00K	$0	$67.00K	$411.00K	$270.00K	$1.13M
Free cash flow	$60.71M	$141.75M	$223.53M	$257.45M	$313.10M	$363.81M	$201.66M	$140.65M	$188.42M	$195.80M
Investing cash flow	-$4.58M	-$23.24M	$3.52M	-$18.00M	-$314.94M	$43.72M	-$56.63M	-$66.76M	-$63.79M	$40.50M
Financing cash flow	-$97.57M	-$163.19M	-$237.97M	-$23.78M	-$29.79M	-$452.50M	-$55.57M	-$171.84M	-$13.45M	$8.55M
Dividends paid	$960.00K	$281.00K	$80.00K	$11.00K	$0	$0	—	—	—	—
Share buybacks	$78.09M	$97.50M	$0	$0	$0	$394.15M	$8.50M	$75.73M	$14.78M	$4.53M
Stock-based compensation	$8.30M	$9.83M	$3.23M	$2.06M	$1.70M	$2.02M	$7.35M	$5.84M	$6.37M	$9.45M
Depreciation & amortization	$13.95M	$13.98M	$13.87M	$13.87M	$13.84M	$13.83M	—	—	—	—

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$85.84M	$77.50M	$99.90M	$89.51M	$91.81M	$88.63M	$100.28M	$107.80M	$114.61M	$97.99M	$119.59M	$106.12M
Gross profit	—	$60.09M	$84.99M	$73.01M	$78.13M	$73.31M	$83.15M	$75.54M	$75.67M	$75.83M	$90.62M	$84.38M
Research & development	$2.36M	$3.88M	$2.56M	$3.55M	$3.67M	$4.40M	$7.98M	$13.67M	$4.55M	$5.24M	$5.19M	$5.21M
Selling, general & admin	$26.32M	$30.41M	$27.74M	$26.22M	$31.33M	$27.49M	$26.41M	$27.29M	$32.12M	$32.44M	$34.57M	$37.02M
Operating income	—	$25.80M	$54.69M	$43.24M	$43.14M	$41.43M	$48.75M	$34.58M	$38.99M	$38.15M	$50.85M	$42.15M
Interest expense	$5.95M	$5.85M	$5.80M	$5.81M	$4.75M	$4.71M	$4.66M	$4.01M	$3.31M	$5.44M	$5.47M	$5.47M
Pre-tax income	$61.20M	$45.12M	-$39.28M	$6.85M	$24.69M	-$38.59M	$72.60M	$97.82M	$195.04M	$234.56M	-$108.02M	-$97.61M
Income tax	-$330.00K	$8.59M	-$4.59M	$5.64M	$4.36M	$8.00M	$8.91M	$7.91M	$30.88M	$47.97M	-$24.60M	-$23.72M
Net income	$61.53M	$36.53M	-$34.69M	$1.21M	$20.33M	-$46.58M	$63.69M	$89.91M	$164.15M	$186.59M	-$83.42M	-$73.89M
EPS (basic)	$0.96	$0.58	$-0.55	$0.02	$0.32	$-0.74	$1.01	$1.30	$2.37	$2.52	$-1.14	$-1.03
EPS (diluted)	$0.75	$0.46	$-0.55	$0.02	$0.31	$-0.74	$0.77	$1.08	$1.95	$2.22	$-1.14	$-1.03
Diluted shares	-628.00K	84.53M	62.53M	62.95M	11.17M	62.71M	84.45M	84.96M	184.00K	84.85M	73.42M	72.07M
Gross margin	—	77.5%	85.1%	81.6%	85.1%	82.7%	82.9%	70.1%	66.0%	77.4%	75.8%	79.5%
Operating margin	—	33.3%	54.7%	48.3%	47.0%	46.7%	48.6%	32.1%	34.0%	38.9%	42.5%	39.7%
Net margin	71.7%	47.1%	-34.7%	1.4%	22.1%	-52.6%	63.5%	83.4%	143.2%	190.4%	-69.8%	-69.6%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$193.51M	$178.36M	$217.00M	$260.63M	$304.96M	$319.09M	$397.53M	$476.51M	$550.94M	$603.09M	$570.39M	$581.39M
Inventory	$40.74M	$37.44M	$36.66M	$34.24M	$33.73M	$41.48M	$49.00M	$38.36M	$39.17M	$38.84M	$38.97M	$42.84M
Total current assets	$344.22M	$311.34M	$358.28M	$400.62M	$554.31M	$582.02M	$651.78M	$684.57M	$727.51M	$772.62M	$753.37M	$772.25M
Goodwill	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M	$17.91M
Total assets	$1.24B	$1.27B	$1.22B	$1.23B	$1.30B	$1.25B	$1.33B	$1.43B	$1.64B	$1.84B	$1.70B	$1.54B
Total current liabilities	$38.13M	$29.88M	$28.21M	$223.75M	$236.08M	$234.75M	$246.56M	$48.47M	$49.70M	$36.56M	$47.06M	$50.03M
Short-term debt	$0	—	—	$191.84M	$192.03M	$192.22M	$191.90M	$0	$0	—	—	—
Long-term debt	$446.23M	$446.76M	$447.28M	$255.97M	$256.32M	$256.67M	$257.02M	$257.38M	$257.73M	$258.10M	$258.45M	$258.82M
Total debt	$446.23M	$446.76M	$447.28M	$447.81M	$448.34M	$448.88M	$448.92M	$257.38M	$257.73M	$258.10M	$258.45M	$258.82M
Total liabilities	$568.55M	$563.93M	$559.40M	$563.07M	$609.90M	$607.49M	$618.75M	$419.15M	$462.32M	$494.93M	$469.46M	$400.41M
Shareholders' equity	$674.96M	$703.68M	$665.51M	$668.54M	$691.16M	$646.90M	$714.82M	$1.01B	$1.17B	$1.34B	$1.23B	$1.14B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$33.26M	$37.05M	$43.72M	$48.69M	$59.24M	$48.62M	$44.07M	$49.73M	$54.51M	$35.28M	$51.97M	$41.70M
Capital expenditures	$151.00K	$0	$0	$270.00K	$0	$0	$0	$1.12M	$10.00K	$492.00K	$429.00K	$24.00K
Free cash flow	$33.10M	$37.05M	$43.72M	$48.42M	$59.24M	$48.62M	$44.07M	$48.61M	$54.50M	$34.79M	$51.54M	$41.67M
Investing cash flow	-$5.15M	-$43.04M	$0	-$5.27M	-$15.48M	-$34.67M	$33.12M	$18.41M	$23.64M	$37.01M	-$55.26M	-$5.43M
Financing cash flow	-$14.59M	-$9.16M	-$5.07M	$211.00K	$573.00K	$183.00K	$1.25M	$10.84M	-$3.72M	-$20.15M	-$29.41M	-$25.26M
Share buybacks	$14.64M	$9.57M	$5.21M	$0	$0	$0	$0	$0	$4.53M	$20.25M	$31.07M	$26.07M
Stock-based compensation	$1.28M	$1.46M	$1.64M	$1.60M	$1.67M	$2.15M	$2.42M	$2.38M	$2.50M	$2.57M	$4.74M	$3.67M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.